Infliximab is a biologic drug that is used to treat a variety of autoimmune diseases such as Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriasis, and rheumatoid arthritis. It works by suppressing the body's immune response to the antigen that is causing inflammation. Infliximab is given by intravenous infusion. Common side effects include headaches, fever, nausea, and rash.
Infliximab, marketed under the brand name Remicade, is a medication classified as a tumor necrosis factor-alpha (TNF-alpha) inhibitor. Here's a breakdown of its key points:
Function:
- Targets TNF-alpha, a protein involved in the body's inflammatory response. In certain autoimmune diseases, excessive TNF-alpha production triggers chronic inflammation leading to tissue damage.
- Infliximab acts as a monoclonal antibody, specifically binding to and neutralizing TNF-alpha, thereby curbing inflammation.
Medical Uses:
- Treats various autoimmune conditions including:
- Rheumatoid arthritis (adults)
- Ankylosing spondylitis (adults)
- Psoriatic arthritis (adults)
- Chronic, severe plaque psoriasis (adults) for whom other treatments are ineffective
- Crohn's disease (adults and children 6 years and older)
- Ulcerative colitis (adults and children 6 years and older)
Administration:
- Administered through intravenous infusion, where the medication is delivered directly into a vein by a healthcare professional.
Important Considerations:
- Prescription medication: Requires strict supervision by a qualified healthcare provider.
- Not for everyone: Individuals with specific medical conditions or weakened immune systems may not be suitable candidates.
- Potential side effects: These can include:
- Increased risk of infections
- Infusion reactions
- Autoimmune reactions
- Blood abnormalities
Disclaimer:
- The information provided here is for educational purposes only and should not be interpreted as medical advice.
- Never attempt to self-medicate with Infliximab or any other medication. Always consult a licensed physician for diagnosis and treatment of any medical condition.
Additional Resources:
- You can find more details about Infliximab on the websites of reputable health organizations like the National Institutes of Health (https://www.nih.gov/) or the Mayo Clinic (https://www.mayo.edu/).
Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L04 Immunosuppressants
L04A - Immunosuppressants
L04AB Tumor necrosis factor alpha (TNF-α) inhibitors
ATC Code
External Links
Infliximab